Kabra Drugs is not listed on NSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 27.12 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 26.59 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 25.56 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 22.71 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 22.27 on BSE
52 Week HighKabra Drugs has hit a 52wk high of Rs 21.00 on BSE
No recommendations so far.What's your call on Kabra Drugs today?
|Company Name||Last Price||%
|Dr Reddys Labs||3187.75||3.34||3199.00||2420.00||54,308.37|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 975.00 44.44%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Kabra Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 11.90 crore.The company has reported a standalone sales of Rs 2.15 crore and a Net Profit of Rs 0.06 crore for the quarter ended Jun 2014.
The company management includes Shyam Kabra - Chairman & Managing Director, Madhusudan Sharma - Director, Mahendra Mandloi - Director.
It is listed on the BSE with a BSE Code of 524322.
Its Registered office is at Plot No.26, Sanwer Road,,Sector A, Indore,Madhya Pradesh - 452003.
Their Registrars are Ankit Consultancy Pvt. Ltd.